I Takasaki
About
In The Last Decade
I Takasaki
21 papers receiving 329 citations
Peers
Comparison fields: 5 of 62
- Cardiology and Cardiovascular Medicine 143
- Molecular Biology 113
- Immunology and Allergy 86
- Cancer Research 75
- Endocrinology, Diabetes and Metabolism 71
Countries citing papers authored by I Takasaki
This map shows the geographic impact of I Takasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Takasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Takasaki more than expected).
Fields of papers citing papers by I Takasaki
This network shows the impact of papers produced by I Takasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Takasaki. The network helps show where I Takasaki may publish in the future.
Co-authorship network of co-authors of I Takasaki
This figure shows the co-authorship network connecting the top 25 collaborators of I Takasaki. A scholar is included among the top collaborators of I Takasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Takasaki. I Takasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Angiotensin-converting enzyme inhibitors: recent therapeutic aspect]. | 1 |
| 2 | 1 | |
| 3 | [Fatal case of tuberous sclerosis with hemorrhage in giant renal angiomyolipoma]. | 2 |
| 4 | 13 | |
| 5 | 5 | |
| 6 | Effect of an angiotensin receptor antagonist, TCV-116, on sympathetic nerve activity in patients with essential hypertension. | 8 |
| 7 | 15 | |
| 8 | 52 | |
| 9 | [Nonpeptide angiotensin II antagonists]. | 4 |
| 10 | 33 | |
| 11 | Hypertensive complications in patients with primary aldosteronism. A retrospective study | 12 |
| 12 | 20 | |
| 13 | 77 | |
| 14 | 7 | |
| 15 | 5 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 4 | |
| 19 | Preoperative lateralisation of aldosteronomas by aldosterone/cortisol ratios in adrenal venous plasma. | 6 |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.